Masimo appointed Katie Szyman as its next chief executive officer and named current interim CEO Michelle Brennan as the new chair of the board. The medical technology company on Tuesday said that the executive changes will be effective Feb.

Szyman led Edwards Lifesciences’ critical care unit for more than a decade before BD acquired the group last year. Her appointment “fits like a glove,” BTIG analyst Marie Thibault wrote.

Masimo Corp. today announced Katie Szyman as its new chief executive, effective Feb. 12. Szyman is currently worldwide president of BD Advanced Patient Monitoring, the former Critical Care unit of Edwards Lifesciences Corp. that was acquired by Becton, Dickinson and Co. last year for $4.2 billion.